Book review: Safety of Biologics Therapy

Tadeusz Robak Department of Hematology, Medical University of Lodz and Copernicus Memorial Hospital, Lodz, PolandSafety of Biologics Therapy: Monoclonal Antibodies, Cytokines, Fusion Proteins, Hormones, Enzymes, Coagulation Proteins, Vaccines, Botulinum Toxins (Cham, Switzerland: Springer Internatio...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autor principal:	Robak T
Formato:	article
Lenguaje:	EN
Publicado:	Dove Medical Press 2017
Materias:	Monoclonal Antibodies Cytokines Fusion Proteins Hormones Enzymes Coagulation Proteins Vaccines Botulinum Toxins Medicine (General) R5-920
Acceso en línea:	https://doaj.org/article/51e02ab4b20049529b94aaf512cfa1ae
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:51e02ab4b20049529b94aaf512cfa1ae
record_format	dspace
spelling	oai:doaj.org-article:51e02ab4b20049529b94aaf512cfa1ae2021-12-02T01:06:38ZBook review: Safety of Biologics Therapy1177-5491https://doaj.org/article/51e02ab4b20049529b94aaf512cfa1ae2017-01-01T00:00:00Zhttps://www.dovepress.com/book-review-safety-of-biologics-therapy-peer-reviewed-article-BTThttps://doaj.org/toc/1177-5491Tadeusz Robak Department of Hematology, Medical University of Lodz and Copernicus Memorial Hospital, Lodz, PolandSafety of Biologics Therapy: Monoclonal Antibodies, Cytokines, Fusion Proteins, Hormones, Enzymes, Coagulation Proteins, Vaccines, Botulinum Toxins (Cham, Switzerland: Springer International Publishing; 2016) by Brian A Baldo from the Molecular Immunology Unit, Kolling Institute of Medical Research, Royal North Shore Hospital of Sydney, and the Department of Medicine, University of Sydney, Australia, is a book that belongs on the shelf of everyone in the field of biologic therapies research and clinical practice. In writing this book, the author’s intention was to produce an up-to-date text book on approved biologic therapies, as far as that is possible in this time of rapidly evolving developments in biotherapeutic research and the introduction of new and novel agents for clinical use.The monograph comprises 610 pages in 13 chapters, each including a summary and further reading suggestions. All chapters include a discussion of basic and clinical material. Well-designed, comprehensive tables and color figures are present throughout the book. The book itself examines the biologic products that have regulatory approval in the USA and/or European Union and that show every indication of remaining important therapies. It covers in great detail all the latest work on peptide hormones and enzymes, monoclonal antibodies, fusion proteins, and cytokine therapies. Beyond that, it also presents the latest information on blood coagulation proteins, vaccines, botulinum neurotoxins, and biosimilars. Robak TDove Medical PressarticleMonoclonal AntibodiesCytokinesFusion ProteinsHormonesEnzymesCoagulation ProteinsVaccinesBotulinum ToxinsMedicine (General)R5-920ENBiologics: Targets & Therapy, Vol Volume 11, Pp 1-3 (2017)
institution	DOAJ
collection	DOAJ
language	EN
topic	Monoclonal Antibodies Cytokines Fusion Proteins Hormones Enzymes Coagulation Proteins Vaccines Botulinum Toxins Medicine (General) R5-920
spellingShingle	Monoclonal Antibodies Cytokines Fusion Proteins Hormones Enzymes Coagulation Proteins Vaccines Botulinum Toxins Medicine (General) R5-920 Robak T Book review: Safety of Biologics Therapy
description	Tadeusz Robak Department of Hematology, Medical University of Lodz and Copernicus Memorial Hospital, Lodz, PolandSafety of Biologics Therapy: Monoclonal Antibodies, Cytokines, Fusion Proteins, Hormones, Enzymes, Coagulation Proteins, Vaccines, Botulinum Toxins (Cham, Switzerland: Springer International Publishing; 2016) by Brian A Baldo from the Molecular Immunology Unit, Kolling Institute of Medical Research, Royal North Shore Hospital of Sydney, and the Department of Medicine, University of Sydney, Australia, is a book that belongs on the shelf of everyone in the field of biologic therapies research and clinical practice. In writing this book, the author’s intention was to produce an up-to-date text book on approved biologic therapies, as far as that is possible in this time of rapidly evolving developments in biotherapeutic research and the introduction of new and novel agents for clinical use.The monograph comprises 610 pages in 13 chapters, each including a summary and further reading suggestions. All chapters include a discussion of basic and clinical material. Well-designed, comprehensive tables and color figures are present throughout the book. The book itself examines the biologic products that have regulatory approval in the USA and/or European Union and that show every indication of remaining important therapies. It covers in great detail all the latest work on peptide hormones and enzymes, monoclonal antibodies, fusion proteins, and cytokine therapies. Beyond that, it also presents the latest information on blood coagulation proteins, vaccines, botulinum neurotoxins, and biosimilars.
format	article
author	Robak T
author_facet	Robak T
author_sort	Robak T
title	Book review: Safety of Biologics Therapy
title_short	Book review: Safety of Biologics Therapy
title_full	Book review: Safety of Biologics Therapy
title_fullStr	Book review: Safety of Biologics Therapy
title_full_unstemmed	Book review: Safety of Biologics Therapy
title_sort	book review: safety of biologics therapy
publisher	Dove Medical Press
publishDate	2017
url	https://doaj.org/article/51e02ab4b20049529b94aaf512cfa1ae
work_keys_str_mv	AT robakt bookreviewsafetyofbiologicstherapy
_version_	1718403314536677376

Book review: Safety of Biologics Therapy

Ejemplares similares